Company intelligence / Profile preview

Renalytix

London, England, United Kingdomrenalytix.com ↗

Ownership: Public · RNLX
Development stage: Commercial

Overview

The company’s lead product, KidneyIntelX™, has received FDA marketing authorization and final Medicare coverage. It uses a proprietary machine learning algorithm to integrate blood biomarkers and patient data to predict the risk of progressive decline in kidney function over five years for adults with type 2 diabetes and early-stage CKD. Clinical validation studies have demonstrated its ability to stratify patients by risk level for targeted intervention.

Therapeutic areas: Nephrology
Modalities: Device (in vitro diagnostic test)Artificial intelligence-enabled algorithmBiomarker-based diagnosticsMachine learning-based risk assessment
Industry: Protein Biomarker Diagnostics

Drug pipeline

1 asset

KidneyIntelX.dkd

Commercial

Indications: Diabetic kidney disease, Chronic kidney disease

Partnerships

Mount Sinai Health System/Icahn School of Medicine at Mount SinaiUniversity of MichiganSinging River Health SystemAstraZenecaNational Kidney Foundation

Financials

Market cap: $22.5M
Total revenue: $522K
Enterprise value: $29.9M

Beyond the preview

Go deeper on Renalytix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renalytix.

Explore the full profile